Sysmex (OTCMKTS:SSMXY) Shares Down 8.7% – What’s Next?

Sysmex Corporation ADR (OTCMKTS:SSMXY) fell 8.7% on Wednesday . The stock traded as low as $9.07 and last traded at $9.07. 1,698 shares were traded during mid-day trading, a decline of 99% from the average session volume of 270,946 shares. The stock had previously closed at $9.93.

Sysmex Stock Performance

The stock has a 50 day moving average of $9.47 and a 200 day moving average of $10.61. The company has a quick ratio of 2.44, a current ratio of 3.33 and a debt-to-equity ratio of 0.12. The firm has a market cap of $5.76 billion, a price-to-earnings ratio of 19.05 and a beta of 1.14.

Sysmex (OTCMKTS:SSMXY) last released its earnings results on Thursday, February 12th. The company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.14 by $0.01. The firm had revenue of $837.32 million for the quarter, compared to analyst estimates of $819.99 million. Sysmex had a net margin of 8.86% and a return on equity of 9.27%. As a group, analysts anticipate that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.